tirzepatide weight loss with ongoing nurse support Can Help You Lose Weight? Your health goals deserve more

Durability of Results: Maintenance Studies: Tirzepatide (SURMOUNT-3): Continued treatment: Additional 5.5% weight loss Stopped treatment: Regained 14% of weight Conclusion: Need ongoing treatment Semaglutide (STEP-4): Continued treatment: Maintained loss, continued losing Stopped treatment: Regained most weight Conclusion: Need ongoing treatment Phentermine: FDA-approved for 12 weeks only Weight regain after stopping is universal Not a long-term solution All Weight Loss Medications: Obesity is chronic disease Medications treat symptoms, dont cure Stopping medication weight regain Long-term or indefinite use necessary for sustained results Safety Profile Comparison: Discontinuation Due to Side Effects: Tirzepatide: 6.2% Semaglutide: 6.9% Liraglutide: 9.9% Naltrexone-bupropion: 25% (very high) Orlistat: 15-20% Phentermine-topiramate: 8-10% GLP-1s have excellent tolerability considering their effectiveness

If you don't have insurance (or if your insurance doesn't cover Ozempic), you may be able to access it at a reduced cash price of $499 per month

In-depth assessment to confirm Tirzepatide suitability

Comparing Pregnancy Guidelines Across GLP-1 Medications Understanding whether other GLP-1 medications have different pregnancy safety profiles might be relevant

There is no measuring, no math, no room for error

No magic pills